centre hospitalier lyon sud ( Site 1102)

Pierre-Bénite, Rhone 69495

1 studies enrolling now · 2 studies all time

What they study most

Melanoma, Renal Cell Carcinoma

Studies at this site

• A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) — Recruiting now
• Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02) — Completed